Longevity research continues to shift from theory to clinical practice, with investors, scientists, and physicians working together to shape the future of healthy aging. The Sheba Longevity Conference, held on May 7–8, 2025, at Sheba Medical Center in Ramat Gan, Israel, brings these groups together to explore how new discoveries can lead to better health outcomes.
LongeVC’s managing partner, Garri Zmudze, will join the conference to share insights on where science and investment align, particularly in the development of new biotech solutions for age-related diseases. Garri serves on the board of the Sheba Longevity Center and continues to support its mission to advance clinical applications of longevity research.
If you're attending the event or based in Israel and would like to connect, reach out to us at hq@longevc.com.
You can find more details of the event here.
LongeVC’s managing partner, Garri Zmudze, will join the conference to share insights on where science and investment align, particularly in the development of new biotech solutions for age-related diseases. Garri serves on the board of the Sheba Longevity Center and continues to support its mission to advance clinical applications of longevity research.
If you're attending the event or based in Israel and would like to connect, reach out to us at hq@longevc.com.
You can find more details of the event here.